OncoLens vs RapidAI
OncoLensClinical Decision Support
CustomPublished price
RapidAIClinical Decision Support
CustomPublished price
OncoLens Clinical Decision Support Timely, Precise Cancer Care | RapidAI Clinical Decision Support Deep clinical AI on an enterprise platform, enhancing AI clinical assessment and transforming care | |
|---|---|---|
| Overview | ||
| Category | Clinical Decision Support | Clinical Decision Support |
| What it is | AI-powered multidisciplinary tumor board platform automating case preparation and treatment recommendations. | AI-powered clinical decision support platform for stroke, pulmonary embolism, and aneurysm detection using advanced brain imaging analysis. |
| Pricing | ||
| Published price | Custom No public pricing; OncoLens is quoted per cancer program/institution. A free virtual tumor board tier has been offered historically, but core enterprise use is custom-quoted. | Custom No public pricing; quote-based per hospital/health-system, priced by which of the 14+ FDA-cleared modules are deployed. RapidAI is eligible for Medicare NTAP reimbursement for LVO… |
| Pricing model | Custom quote | Custom quote |
| Free options | Free plan · No free trial | No free plan · No free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2017 | 2012 |
| Team size | 11-50 employees | 201-500 employees |
| Headquarters | Dallas, TX | San Mateo, CA |